Global Anti-Emetic Drug Market Growth 2020-2025

Tables and Figures

List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Anti-Emetic Drug Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Oral
Table 5. Major Players of Injection
Table 6. Major Players of Others
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Anti-Emetic Drug Consumption Market Share by Type (2015-2020)
Table 9. Global Anti-Emetic Drug Revenue by Type (2015-2020) ($ million)
Table 10. Global Anti-Emetic Drug Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Anti-Emetic Drug Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Anti-Emetic Drug Consumption Market Share by Application (2015-2020)
Table 14. Global Anti-Emetic Drug Value by Application (2015-2020)
Table 15. Global Anti-Emetic Drug Value Market Share by Application (2015-2020)
Table 16. Global Anti-Emetic Drug Sale Price by Application (2015-2020)
Table 17. Global Anti-Emetic Drug Sales by Company (2017-2019) (K Units)
Table 18. Global Anti-Emetic Drug Sales Market Share by Company (2017-2019)
Table 19. Global Anti-Emetic Drug Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Anti-Emetic Drug Revenue Market Share by Company (2017-2019)
Table 21. Global Anti-Emetic Drug Sale Price by Company (2017-2019)
Table 22. Global Anti-Emetic Drug Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Anti-Emetic Drug Products Offered
Table 24. Anti-Emetic Drug Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Anti-Emetic Drug Consumption by Regions 2015-2020 (K Units)
Table 26. Global Anti-Emetic Drug Consumption Market Share by Regions 2015-2020
Table 27. Global Anti-Emetic Drug Value by Regions 2015-2020 ($ Millions)
Table 28. Global Anti-Emetic Drug Value Market Share by Regions 2015-2020
Table 29. Americas Anti-Emetic Drug Consumption by Countries (2015-2020) (K Units)
Table 30. Americas Anti-Emetic Drug Consumption Market Share by Countries (2015-2020)
Table 31. Americas Anti-Emetic Drug Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Anti-Emetic Drug Value Market Share by Countries (2015-2020)
Table 33. Americas Anti-Emetic Drug Consumption by Type (2015-2020) (K Units)
Table 34. Americas Anti-Emetic Drug Consumption Market Share by Type (2015-2020)
Table 35. Americas Anti-Emetic Drug Consumption by Application (2015-2020) (K Units)
Table 36. Americas Anti-Emetic Drug Consumption Market Share by Application (2015-2020)
Table 37. APAC Anti-Emetic Drug Consumption by Regions (2015-2020) (K Units)
Table 38. APAC Anti-Emetic Drug Consumption Market Share by Regions (2015-2020)
Table 39. APAC Anti-Emetic Drug Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Anti-Emetic Drug Value Market Share by Regions (2015-2020)
Table 41. APAC Anti-Emetic Drug Consumption by Type (2015-2020) (K Units)
Table 42. APAC Anti-Emetic Drug Consumption Market Share by Type (2015-2020)
Table 43. APAC Anti-Emetic Drug Consumption by Application (2015-2020) (K Units)
Table 44. APAC Anti-Emetic Drug Consumption Market Share by Application (2015-2020)
Table 45. Europe Anti-Emetic Drug Consumption by Countries (2015-2020) (K Units)
Table 46. Europe Anti-Emetic Drug Consumption Market Share by Countries (2015-2020)
Table 47. Europe Anti-Emetic Drug Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Anti-Emetic Drug Value Market Share by Countries (2015-2020)
Table 49. Europe Anti-Emetic Drug Consumption by Type (2015-2020) (K Units)
Table 50. Europe Anti-Emetic Drug Consumption Market Share by Type (2015-2020)
Table 51. Europe Anti-Emetic Drug Consumption by Application (2015-2020) (K Units)
Table 52. Europe Anti-Emetic Drug Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Anti-Emetic Drug Consumption by Countries (2015-2020) (K Units)
Table 54. Middle East & Africa Anti-Emetic Drug Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Anti-Emetic Drug Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Anti-Emetic Drug Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Anti-Emetic Drug Consumption by Type (2015-2020) (K Units)
Table 58. Middle East & Africa Anti-Emetic Drug Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Anti-Emetic Drug Consumption by Application (2015-2020) (K Units)
Table 60. Middle East & Africa Anti-Emetic Drug Consumption Market Share by Application (2015-2020)
Table 61. Anti-Emetic Drug Distributors List
Table 62. Anti-Emetic Drug Customer List
Table 63. Global Anti-Emetic Drug Consumption Forecast by Countries (2021-2025) (K Units)
Table 64. Global Anti-Emetic Drug Consumption Market Forecast by Regions
Table 65. Global Anti-Emetic Drug Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Anti-Emetic Drug Value Market Share Forecast by Regions
Table 67. Global Anti-Emetic Drug Consumption Forecast by Type (2021-2025) (K Units)
Table 68. Global Anti-Emetic Drug Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Anti-Emetic Drug Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Anti-Emetic Drug Value Market Share Forecast by Type (2021-2025)
Table 71. Global Anti-Emetic Drug Consumption Forecast by Application (2021-2025) (K Units)
Table 72. Global Anti-Emetic Drug Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Anti-Emetic Drug Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Anti-Emetic Drug Value Market Share Forecast by Application (2021-2025)
Table 75. Merck Product Offered
Table 76. Merck Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 77. Merck Main Business
Table 78. Merck Latest Developments
Table 79. Merck Basic Information, Company Total Revenue (in $ million), Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 80. Akorn Product Offered
Table 81. Akorn Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 82. Akorn Main Business
Table 83. Akorn Latest Developments
Table 84. Akorn Basic Information, Company Total Revenue (in $ million), Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 85. Novartis Product Offered
Table 86. Novartis Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 87. Novartis Main Business
Table 88. Novartis Latest Developments
Table 89. Novartis Basic Information, Company Total Revenue (in $ million), Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 90. F. Hoffmann-La Roche Product Offered
Table 91. F. Hoffmann-La Roche Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 92. F. Hoffmann-La Roche Main Business
Table 93. F. Hoffmann-La Roche Latest Developments
Table 94. F. Hoffmann-La Roche Basic Information, Company Total Revenue (in $ million), Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Heron Therapeutics Product Offered
Table 96. Heron Therapeutics Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 97. Heron Therapeutics Main Business
Table 98. Heron Therapeutics Latest Developments
Table 99. Heron Therapeutics Basic Information, Company Total Revenue (in $ million), Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Glenmark Pharmaceuticals Product Offered
Table 101. Glenmark Pharmaceuticals Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 102. Glenmark Pharmaceuticals Main Business
Table 103. Glenmark Pharmaceuticals Latest Developments
Table 104. Glenmark Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Mylan Product Offered
Table 106. Mylan Basic Information, Company Total Revenue (in $ million), Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Mylan Main Business
Table 108. Mylan Latest Developments
Table 109. Mylan Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 110. Kyowa Kirin Product Offered
Table 111. Kyowa Kirin Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 112. Kyowa Kirin Main Business
Table 113. Kyowa Kirin Latest Developments
Table 114. Kyowa Kirin Basic Information, Company Total Revenue (in $ million), Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. Hikma Product Offered
Table 116. Hikma Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 117. Hikma Main Business
Table 118. Hikma Latest Developments
Table 119. Hikma Basic Information, Company Total Revenue (in $ million), Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Aurobindo Pharma Product Offered
Table 121. Aurobindo Pharma Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 122. Aurobindo Pharma Main Business
Table 123. Aurobindo Pharma Latest Developments
Table 124. Aurobindo Pharma Basic Information, Company Total Revenue (in $ million), Anti-Emetic Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. Teva Pharmaceutical Product Offered
Table 126. Teva Pharmaceutical Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 127. Teva Pharmaceutical Main Business
Table 128. Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Teva Pharmaceutical Latest Developments
Table 130. Pfizer Product Offered
Table 131. Pfizer Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 132. Pfizer Main Business
Table 133. Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 134. Pfizer Latest Developments
Table 135. Dr. Reddy's Laboratories Product Offered
Table 136. Dr. Reddy's Laboratories Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 137. Dr. Reddy's Laboratories Main Business
Table 138. Dr. Reddy's Laboratories Latest Developments
Table 139. Dr. Reddy's Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 140. Wockhardt Product Offered
Table 141. Wockhardt Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 142. Wockhardt Main Business
Table 143. Wockhardt Latest Developments
Table 144. Wockhardt Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 145. Fresenius Kabi Product Offered
Table 146. Fresenius Kabi Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 147. Fresenius Kabi Main Business
Table 148. Fresenius Kabi Latest Developments
Table 149. Fresenius Kabi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 150. Sun Pharmaceutical Industries Product Offered
Table 151. Sun Pharmaceutical Industries Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 152. Sun Pharmaceutical Industries Main Business
Table 153. Sun Pharmaceutical Industries Latest Developments
Table 154. Sun Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 155. Cipla Product Offered
Table 156. Cipla Anti-Emetic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 157. Cipla Main Business
Table 158. Cipla Latest Developments
Table 159. Cipla Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Anti-Emetic Drug
Figure 2. Anti-Emetic Drug Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Anti-Emetic Drug Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Anti-Emetic Drug Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Oral
Figure 7. Product Picture of Injection
Figure 8. Product Picture of Others
Figure 9. Global Anti-Emetic Drug Consumption Market Share by Type (2015-2020)
Figure 10. Global Anti-Emetic Drug Value Market Share by Type (2015-2020)
Figure 11. Anti-Emetic Drug Consumed in Hospital
Figure 12. Global Anti-Emetic Drug Market: Hospital (2015-2020) (K Units)
Figure 13. Global Anti-Emetic Drug Market: Hospital (2015-2020) ($ Millions)
Figure 14. Anti-Emetic Drug Consumed in Clinic
Figure 15. Global Anti-Emetic Drug Market: Clinic (2015-2020) (K Units)
Figure 16. Global Anti-Emetic Drug Market: Clinic (2015-2020) ($ Millions)
Figure 17. Anti-Emetic Drug Consumed in Home Care
Figure 18. Global Anti-Emetic Drug Market: Home Care (2015-2020) (K Units)
Figure 19. Global Anti-Emetic Drug Market: Home Care (2015-2020) ($ Millions)
Figure 20. Anti-Emetic Drug Consumed in Others
Figure 21. Global Anti-Emetic Drug Market: Others (2015-2020) (K Units)
Figure 22. Global Anti-Emetic Drug Market: Others (2015-2020) ($ Millions)
Figure 23. Global Anti-Emetic Drug Consumption Market Share by Application (2015-2020)
Figure 24. Global Anti-Emetic Drug Value Market Share by Application (2015-2020)
Figure 25. Global Anti-Emetic Drug Sales Market Share by Company in 2017
Figure 26. Global Anti-Emetic Drug Sales Market Share by Company in 2019
Figure 27. Global Anti-Emetic Drug Revenue Market Share by Company in 2017
Figure 28. Global Anti-Emetic Drug Revenue Market Share by Company in 2019
Figure 29. Global Anti-Emetic Drug Sale Price by Company in 2019
Figure 30. Global Anti-Emetic Drug Consumption Market Share by Regions 2015-2020
Figure 31. Global Anti-Emetic Drug Value Market Share by Regions 2015-2020
Figure 32. Americas Anti-Emetic Drug Consumption 2015-2020 (K Units)
Figure 33. Americas Anti-Emetic Drug Value 2015-2020 ($ Millions)
Figure 34. APAC Anti-Emetic Drug Consumption 2015-2020 (K Units)
Figure 35. APAC Anti-Emetic Drug Value 2015-2020 ($ Millions)
Figure 36. Europe Anti-Emetic Drug Consumption 2015-2020 (K Units)
Figure 37. Europe Anti-Emetic Drug Value 2015-2020 ($ Millions)
Figure 38. Middle East & Africa Anti-Emetic Drug Consumption 2015-2020 (K Units)
Figure 39. Middle East & Africa Anti-Emetic Drug Value 2015-2020 ($ Millions)
Figure 40. Americas Anti-Emetic Drug Consumption Market Share by Countries in 2019
Figure 41. Americas Anti-Emetic Drug Value Market Share by Countries in 2019
Figure 42. Americas Anti-Emetic Drug Consumption Market Share by Type in 2019
Figure 43. Americas Anti-Emetic Drug Consumption Market Share by Application in 2019
Figure 44. United States Anti-Emetic Drug Consumption Growth 2015-2020 (K Units)
Figure 45. United States Anti-Emetic Drug Value Growth 2015-2020 ($ Millions)
Figure 46. Canada Anti-Emetic Drug Consumption Growth 2015-2020 (K Units)
Figure 47. Canada Anti-Emetic Drug Value Growth 2015-2020 ($ Millions)
Figure 48. Mexico Anti-Emetic Drug Consumption Growth 2015-2020 (K Units)
Figure 49. Mexico Anti-Emetic Drug Value Growth 2015-2020 ($ Millions)
Figure 50. APAC Anti-Emetic Drug Consumption Market Share by Countries in 2019
Figure 51. APAC Anti-Emetic Drug Value Market Share by Regions in 2019
Figure 52. APAC Anti-Emetic Drug Consumption Market Share by Type in 2019
Figure 53. APAC Anti-Emetic Drug Consumption Market Share by Application in 2019
Figure 54. China Anti-Emetic Drug Consumption Growth 2015-2020 (K Units)
Figure 55. China Anti-Emetic Drug Value Growth 2015-2020 ($ Millions)
Figure 56. Japan Anti-Emetic Drug Consumption Growth 2015-2020 (K Units)
Figure 57. Japan Anti-Emetic Drug Value Growth 2015-2020 ($ Millions)
Figure 58. Korea Anti-Emetic Drug Consumption Growth 2015-2020 (K Units)
Figure 59. Korea Anti-Emetic Drug Value Growth 2015-2020 ($ Millions)
Figure 60. Southeast Asia Anti-Emetic Drug Consumption Growth 2015-2020 (K Units)
Figure 61. Southeast Asia Anti-Emetic Drug Value Growth 2015-2020 ($ Millions)
Figure 62. India Anti-Emetic Drug Consumption Growth 2015-2020 (K Units)
Figure 63. India Anti-Emetic Drug Value Growth 2015-2020 ($ Millions)
Figure 64. Australia Anti-Emetic Drug Consumption Growth 2015-2020 (K Units)
Figure 65. Australia Anti-Emetic Drug Value Growth 2015-2020 ($ Millions)
Figure 66. Europe Anti-Emetic Drug Consumption Market Share by Countries in 2019
Figure 67. Europe Anti-Emetic Drug Value Market Share by Countries in 2019
Figure 68. Europe Anti-Emetic Drug Consumption Market Share by Type in 2019
Figure 69. Europe Anti-Emetic Drug Consumption Market Share by Application in 2019
Figure 70. Germany Anti-Emetic Drug Consumption Growth 2015-2020 (K Units)
Figure 71. Germany Anti-Emetic Drug Value Growth 2015-2020 ($ Millions)
Figure 72. France Anti-Emetic Drug Consumption Growth 2015-2020 (K Units)
Figure 73. France Anti-Emetic Drug Value Growth 2015-2020 ($ Millions)
Figure 74. UK Anti-Emetic Drug Consumption Growth 2015-2020 (K Units)
Figure 75. UK Anti-Emetic Drug Value Growth 2015-2020 ($ Millions)
Figure 76. Italy Anti-Emetic Drug Consumption Growth 2015-2020 (K Units)
Figure 77. Italy Anti-Emetic Drug Value Growth 2015-2020 ($ Millions)
Figure 78. Russia Anti-Emetic Drug Consumption Growth 2015-2020 (K Units)
Figure 79. Russia Anti-Emetic Drug Value Growth 2015-2020 ($ Millions)
Figure 80. Middle East & Africa Anti-Emetic Drug Consumption Market Share by Countries in 2019
Figure 81. Middle East & Africa Anti-Emetic Drug Value Market Share by Countries in 2019
Figure 82. Middle East & Africa Anti-Emetic Drug Consumption Market Share by Type in 2019
Figure 83. Middle East & Africa Anti-Emetic Drug Consumption Market Share by Application in 2019
Figure 84. Egypt Anti-Emetic Drug Consumption Growth 2015-2020 (K Units)
Figure 85. Egypt Anti-Emetic Drug Value Growth 2015-2020 ($ Millions)
Figure 86. South Africa Anti-Emetic Drug Consumption Growth 2015-2020 (K Units)
Figure 87. South Africa Anti-Emetic Drug Value Growth 2015-2020 ($ Millions)
Figure 88. Israel Anti-Emetic Drug Consumption Growth 2015-2020 (K Units)
Figure 89. Israel Anti-Emetic Drug Value Growth 2015-2020 ($ Millions)
Figure 90. Turkey Anti-Emetic Drug Consumption Growth 2015-2020 (K Units)
Figure 91. Turkey Anti-Emetic Drug Value Growth 2015-2020 ($ Millions)
Figure 92. GCC Countries Anti-Emetic Drug Consumption Growth 2015-2020 (K Units)
Figure 93. GCC Countries Anti-Emetic Drug Value Growth 2015-2020 ($ Millions)
Figure 94. Global Anti-Emetic Drug Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 95. Global Anti-Emetic Drug Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 96. Americas Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 97. Americas Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 98. APAC Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 99. APAC Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 100. Europe Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 101. Europe Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 102. Middle East & Africa Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 103. Middle East & Africa Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 104. United States Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 105. United States Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 106. Canada Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 107. Canada Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 108. Mexico Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 109. Mexico Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 110. Brazil Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 111. Brazil Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 112. China Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 113. China Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 114. Japan Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 115. Japan Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 116. Korea Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 117. Korea Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 118. Southeast Asia Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 119. Southeast Asia Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 120. India Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 121. India Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 122. Australia Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 123. Australia Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 124. Germany Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 125. Germany Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 126. France Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 127. France Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 128. UK Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 129. UK Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 130. Italy Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 131. Italy Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 132. Russia Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 133. Russia Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 134. Spain Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 135. Spain Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 136. Egypt Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 137. Egypt Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 138. South Africa Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 139. South Africa Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 140. Israel Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 141. Israel Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 142. Turkey Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 143. Turkey Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 144. GCC Countries Anti-Emetic Drug Consumption 2021-2025 (K Units)
Figure 145. GCC Countries Anti-Emetic Drug Value 2021-2025 ($ Millions)
Figure 146. Merck Anti-Emetic Drug Market Share (2018-2020)
Figure 147. Akorn Anti-Emetic Drug Market Share (2018-2020)
Figure 148. Novartis Anti-Emetic Drug Market Share (2018-2020)
Figure 149. F. Hoffmann-La Roche Anti-Emetic Drug Market Share (2018-2020)
Figure 150. Heron Therapeutics Anti-Emetic Drug Market Share (2018-2020)
Figure 151. Glenmark Pharmaceuticals Anti-Emetic Drug Market Share (2018-2020)
Figure 152. Mylan Anti-Emetic Drug Market Share (2018-2020)
Figure 153. Kyowa Kirin Anti-Emetic Drug Market Share (2018-2020)
Figure 154. Hikma Anti-Emetic Drug Market Share (2018-2020)
Figure 155. Aurobindo Pharma Anti-Emetic Drug Market Share (2018-2020)
Figure 156. Teva Pharmaceutical Anti-Emetic Drug Market Share (2018-2020)
Figure 157. Pfizer Anti-Emetic Drug Market Share (2018-2020)
Figure 158. Dr. Reddy's Laboratories Anti-Emetic Drug Market Share (2018-2020)
Figure 159. Wockhardt Anti-Emetic Drug Market Share (2018-2020)
Figure 160. Fresenius Kabi Anti-Emetic Drug Market Share (2018-2020)
Figure 161. Sun Pharmaceutical Industries Anti-Emetic Drug Market Share (2018-2020)
Figure 162. Cipla Anti-Emetic Drug Market Share (2018-2020)

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets